CausalSentinel

Protein Dossier — GP1BA (Platelet glycoprotein Ib alpha chain)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Juvenile idiopathic arthritis 0.991 0.21 2.34e-06 Inverse variance weighted 2 cis 0.702
Juvenile idiopathic arthritis 0.991 0.21 2.34e-06 Inverse variance weighted 2 trans 0.968
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.254 0.06 2.41e-05 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.254 0.06 2.41e-05 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R14 Flatulence and related conditions 0.721 0.211 6.31e-04 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R14 Flatulence and related conditions 0.721 0.211 6.31e-04 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.194 0.0569 6.61e-04 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.194 0.0569 6.61e-04 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: vaginal prolapse or uterine prolapse 0.329 0.0976 7.38e-04 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: vaginal prolapse or uterine prolapse 0.329 0.0976 7.38e-04 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.288 0.0907 0.00152 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.288 0.0907 0.00152 Inverse variance weighted 2 trans NA
…and 232 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4990_87_1 GP1BA Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

49 association rows across 20 traits (48 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Platelet count 6e-362 rs6065 13 GCST90662907 MR: beta=16.5, p=0.00573 (cis)
Hematological traits (multi-trait analysis) 2e-87 rs6065 1 GCST90838669 no MR -> candidate analysis
Circulating GP1BA levels 2e-71 rs553749201 1 GCST90860435 no MR -> candidate analysis
Platelet distribution width (UKB data field 30110) 1e-66 rs553749201 2 GCST90468097 no MR -> candidate analysis
GP1BA protein levels 2e-66 rs553749201 2 GCST90469380 no MR -> candidate analysis
Mean platelet thrombocyte volume (UKB data field 30100) 8e-54 rs6065 3 GCST90468087 no MR -> candidate analysis
Mean platelet volume 2e-53 rs772106076 8 GCST90025960 MR: beta=-0.00522, p=0.404 (cis)
Platelet count (UKB data field 30080) 8e-53 rs553749201 2 GCST90468095 no MR -> candidate analysis
Platelet distribution width 3e-41 rs553749201 6 GCST90002401 no MR -> candidate analysis
Platelet crit (UKB data field 30090) 7e-23 rs553749201 1 GCST90468096 no MR -> candidate analysis
Plateletcrit 2e-18 rs553749201 1 GCST90002400 no MR -> candidate analysis
GP1BB protein levels 5e-18 rs56337033 1 GCST90469381 no MR -> candidate analysis
…and 8 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 402 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Bernard-Soulier syndrome 0.919 established (curated) no MR -> candidate analysis
platelet-type von Willebrand disease 0.869 established (curated) no MR -> candidate analysis
Optic neuropathy 0.862 established (curated) no MR -> candidate analysis
Macrothrombocytopenia 0.772 established (curated) no MR -> candidate analysis
Thrombocytopenia 0.603 established (curated) no MR -> candidate analysis
autosomal dominant macrothrombocytopenia 0.608 established (curated) no MR -> candidate analysis
Abnormal bleeding 0.564 established (curated) no MR -> candidate analysis
Impaired ristocetin-induced platelet aggregation 0.438 established (curated) no MR -> candidate analysis
mathematical ability 0.388 common-variant locus no MR -> candidate analysis
hereditary disease 0.317 established (curated) no MR -> candidate analysis
liver disorder 0.14 common-variant locus no MR -> candidate analysis

Of the 11 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Platelet glycoprotein Ib alpha chain)
gnomAD constraint pLI=0.16, LOEUF=1.38 — LoF-tolerant
GWAS Catalog 95 unique SNPs / 190 rows
ClinVar 386 records; 11 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance